ERTAPENEM FOR INJECTION Poudre pour solution

País: Canadà

Idioma: francès

Font: Health Canada

ingredients actius:

Ertapénem (Ertapénem sodique)

Disponible des:

JUNO PHARMACEUTICALS CORP.

Codi ATC:

J01DH03

Designació comuna internacional (DCI):

ERTAPENEM

Dosis:

1G

formulario farmacéutico:

Poudre pour solution

Composición:

Ertapénem (Ertapénem sodique) 1G

Vía de administración:

Intramusculaire

Unidades en paquete:

15G/50G

tipo de receta:

Prescription

Área terapéutica:

CARBAPENEMS

Resumen del producto:

Numéro de groupe d'ingrédients actifs (GIA) :0149104002; AHFS:

Estat d'Autorització:

APPROUVÉ

Data d'autorització:

2020-05-06

Fitxa tècnica

PM-Ertapenem-FR
Pg. 1
(U
SpQHP SRULQMHF LRQ
3
H
GH
7DEOHGHV PDLqUHV
37,( ,(16(,*1(
(176 328 /(32)(66,211(/( /
6
17e
5(16(,*1(0(1766200 ,5(6 685/( 3528,7
,1,
7,216(786
*(
/,1,48(
2175( ,1,7,216
0,6(6(1* 5 ( (7 35e87,216
())(76 ,1e6,5 %/(6
,17(5
7,216 0e ,
0(17(86(6
3262/2*,( (7
0,1,6757,21
685 26*(
02 (¶7,21(7 3+ 502/2*,(
/,1,48(
67%,/,7e (7(175(326
*(
)250(63262/2*,48(6
20326,7,21 (7
21 ,7,211(0(17
37,( ,,
(16(,*1((176 6,(17,),48(6
5(16(,*1(0(176 3+50
(87,48(6
e78(6
/,1,48(6
3+502/2*,(
e7,//e(
0,
52%,2/2*,(
72;,
2/2*,(
5e)e5(1(6
(16(,*1((176328/( 37,(17 68 /(
e ,
(17
PM-Ertapenem-FR
Pg. 2
PM-Ertapenem-FR
Pg. 3
(U
SpQHP SRULQMHF LRQ
3
H
GH
,QIHF LRQV SHOYLHQQHV DLJXsV
FRPSULV O HQGRP RPp UL H GXSRV SDU XP O DYRU HPHQ
VHS LTXH H
OHV LQIHF LRQV J QpFRORJLTXHVSRV RSpUD RLUHV FDXVpHV SDU6 UHSRFRFF V
F LH
(VFKHULFKL
FRL
3HS RV UHSRFRFF V VSS
F HURLGHV IULLV
3RUSK URPRQ V
VFFK UR
LF
RX3UH R H
VSS
3RXU UpGXLUH O¶DSSDULWLRQ GH EDFWpULHV SKDUPDFRUpVLVWDQWHV HWSRXU
PDLQWHQLU O¶HIILFDFLWp G¶(UWDSpQHP
SRXU LQMHFWLRQ HW GHV DXWUHVPpGLFDPHQWV DQWLEDFWpULHQV (UWDSpQHPSRXU
LQMHFWLRQ GRLWrWUHXWLOLVp
XQLTXHPHQW SRXUWUDLWHUOHV LQIHFWLRQV SRXU OHVTXHOOHV LOHVW GpPRQWUp RX
IRUWHPHQW SUpVXPp TXH GHV
EDFWpULHV VHQVLEOHV HQVRQWOD FDXVH /RUVTXH GHV UHQVHLJQHPHQWV
FRQFHUQDQW OHVFXOWXUHV HW OD
VHQVLELOLWp VRQWGLVSRQLEOHV LOIDXW HQWHQLU FRPSWH SRXU FKRLVLU RX
PRGLILHUXQWUDLWHPHQW
DQWLEDFWpULHQ (Q O¶DEVHQFH GH WHOOHV GRQQpHV OHV SURILOV ORFDX[
G¶pSLGpPLRORJLH HWGH VHQVLELOLWp
SHXYHQW FRQWULEXHU DXFKRL[HPSLULTXH GXWUDLWHPHQW
2QGRLW SUpOHYHU GHVpFKDQWLOORQV DSSURSULpV
HQYXHGHVWHVWVEDFWpULRORJLTXHV SHUPHWWDQWG¶LVROHU
HWG¶LGHQWLILHU OHV PLFUR RUJDQLVPHV UHVSRQVDEOHVGHO¶LQIHFWLRQHW
GHGpWHUPLQHUOHXU VHQVLELOLWp
jO¶HUWDSpQHP2QSHXW LQVWDXUHU XQWUDLWHPHQW LQLWLDOHPSLULTXHDX PR HQ
G¶(UWDSpQHP SRXU
LQMHFWLRQ GDQVOHV FDVG¶LQIHFWLRQ EDFWpULHQQH
FRPSULVOHVLQIHFWLRQV PL[WHV HQDWWHQGDQW OHV
UpVXOWDWV GHVWHVWV EDFWpULRORJLTXHV /H WUDLWHPHQW DQWLPLFURELHQ GRLW
HQVXLWH rWUHDMXVWp VHORQOHV
UpVXOWDWVGHFHVWHVWV
3UpYHQLRQ
(UWDSpQHP
SRXULQMHFWLRQHVWLQGLT